{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:33:40Z","timestamp":1790188420663,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T00:00:00Z","timestamp":1409184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes &amp; Diseases"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.gendis.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T16:07:34Z","timestamp":1406131654000},"page":"40-52","source":"Crossref","is-referenced-by-count":17,"title":["Lung gene therapy\u2014How to capture illumination from the light already present in the tunnel"],"prefix":"10.1016","volume":"1","author":[{"given":"Emily","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunatha Ankathatti","family":"Munegowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9400-0826","authenticated-orcid":false,"given":"Huibi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.gendis.2014.06.001_bib1","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber's congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.gendis.2014.06.001_bib2","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N Engl J Med"},{"issue":"39","key":"10.1016\/j.gendis.2014.06.001_bib3","doi-asserted-by":"crossref","first-page":"15112","DOI":"10.1073\/pnas.0807027105","article-title":"Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics","volume":"105","author":"Cideciyan","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.gendis.2014.06.001_bib4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/humu.20010","article-title":"Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis","volume":"23","author":"Hanein","year":"2004","journal-title":"Hum Mutat"},{"issue":"120","key":"10.1016\/j.gendis.2014.06.001_bib5","doi-asserted-by":"crossref","first-page":"120ra115","DOI":"10.1126\/scitranslmed.3002865","article-title":"AAV2 gene therapy readministration in three adults with congenital blindness","volume":"4","author":"Bennett","year":"2012","journal-title":"Sci Transl Med"},{"issue":"9923","key":"10.1016\/j.gendis.2014.06.001_bib6","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","article-title":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial","volume":"383","author":"Maclaren","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/humc.2013.087","article-title":"Lessons learned from the clinical development and market authorization of Glybera","volume":"24","author":"Bryant","year":"2013","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"10","key":"10.1016\/j.gendis.2014.06.001_bib8","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/mt.2012.194","article-title":"Endgame: glybera finally recommended for approval as the first gene therapy drug in the European Union","volume":"20","author":"Yla-Herttuala","year":"2012","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/j.gendis.2014.06.001_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd3572-c1","article-title":"Glybera and the future of gene therapy in the European Union","volume":"11","author":"Miller","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.gendis.2014.06.001_bib10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s13238-011-1126-y","article-title":"Gene therapy: light is finally in the tunnel","volume":"2","author":"Cao","year":"2011","journal-title":"Protein Cell"},{"issue":"R1","key":"10.1016\/j.gendis.2014.06.001_bib11","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1093\/hmg\/ddt372","article-title":"Moving forward: cystic fibrosis gene therapy","volume":"22","author":"Griesenbach","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.gendis.2014.06.001_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.trsl.2012.12.001","article-title":"Gene therapy in cystic fibrosis","volume":"161","author":"Prickett","year":"2013","journal-title":"Transl Res"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.mt.6300002","article-title":"Viral vector-mediated and cell-based therapies for treatment of cystic fibrosis","volume":"15","author":"Flotte","year":"2007","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"4922","key":"10.1016\/j.gendis.2014.06.001_bib14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: chromosome walking and jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"issue":"4922","key":"10.1016\/j.gendis.2014.06.001_bib15","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis","volume":"245","author":"Kerem","year":"1989","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.gendis.2014.06.001_bib16","first-page":"932","article-title":"Physical localization of two DNA markers closely linked to the cystic fibrosis locus by pulsed-field gel electrophoresis","volume":"45","author":"Rommens","year":"1989","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/mthe.2001.0435","article-title":"Challenges and strategies for cystic fibrosis lung gene therapy","volume":"4","author":"Koehler","year":"2001","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0092-8674(93)80063-K","article-title":"Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis","volume":"75","author":"Zabner","year":"1993","journal-title":"Cell"},{"issue":"6500","key":"10.1016\/j.gendis.2014.06.001_bib19","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/371802a0","article-title":"Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans","volume":"371","author":"Grubb","year":"1994","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.gendis.2014.06.001_bib20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/hum.1994.5.5-615","article-title":"Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity","volume":"5","author":"Boucher","year":"1994","journal-title":"Hum Gene Ther"},{"issue":"13","key":"10.1016\/j.gendis.2014.06.001_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJM199509283331302","article-title":"A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis","volume":"333","author":"Knowles","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ng0994-42","article-title":"Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis","volume":"8","author":"Crystal","year":"1994","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/hum.1997.8.1-15","article-title":"Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial","volume":"8","author":"Bellon","year":"1997","journal-title":"Hum Gene Ther"},{"issue":"9","key":"10.1016\/j.gendis.2014.06.001_bib24","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1172\/JCI7935","article-title":"Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus","volume":"104","author":"Harvey","year":"1999","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.gendis.2014.06.001_bib25","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1089\/104303401750298535","article-title":"Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications","volume":"12","author":"Joseph","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"11","key":"10.1016\/j.gendis.2014.06.001_bib26","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1089\/104303401750298544","article-title":"Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium","volume":"12","author":"Perricone","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"2 Pt 1","key":"10.1016\/j.gendis.2014.06.001_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00005537-199902000-00017","article-title":"Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus","volume":"109","author":"Wagner","year":"1999","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.125.2.509","article-title":"Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial","volume":"125","author":"Moss","year":"2004","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nm0195-39","article-title":"Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis","volume":"1","author":"Caplen","year":"1995","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.gendis.2014.06.001_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.gt.3300391","article-title":"A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis","volume":"4","author":"Gill","year":"1997","journal-title":"Gene Ther"},{"issue":"3","key":"10.1016\/j.gendis.2014.06.001_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/sj.gt.3300390","article-title":"Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis","volume":"4","author":"Porteous","year":"1997","journal-title":"Gene Ther"},{"issue":"6","key":"10.1016\/j.gendis.2014.06.001_bib32","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1172\/JCI119676","article-title":"Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in\u00a0vivo","volume":"100","author":"Zabner","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mthe.1999.0009","article-title":"Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis","volume":"1","author":"Noone","year":"2000","journal-title":"Mol Ther"},{"issue":"9157","key":"10.1016\/j.gendis.2014.06.001_bib34","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(98)06532-5","article-title":"Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial","volume":"353","author":"Alton","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.gendis.2014.06.001_bib35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/104303401750148667","article-title":"A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis","volume":"12","author":"Ruiz","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"3","key":"10.1016\/j.gendis.2014.06.001_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/vim.2004.17.327","article-title":"Adenoviral vectors for gene replacement therapy","volume":"17","author":"Cao","year":"2004","journal-title":"Viral Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2014.06.001_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/rmv.386","article-title":"The impact of adenovirus infection on the immunocompromised host","volume":"13","author":"Kojaoghlanian","year":"2003","journal-title":"Rev Med Virol"},{"issue":"8","key":"10.1016\/j.gendis.2014.06.001_bib38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1089\/hum.2007.022","article-title":"Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial","volume":"18","author":"Moss","year":"2007","journal-title":"Hum Gene Ther"},{"issue":"11","key":"10.1016\/j.gendis.2014.06.001_bib39","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/104303402760128577","article-title":"A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies","volume":"13","author":"Wagner","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.gendis.2014.06.001_bib40","first-page":"1","article-title":"Biology of adeno-associated virus","volume":"218","author":"Berns","year":"1996","journal-title":"Curr Top Microbiol Immunol"},{"issue":"10","key":"10.1016\/j.gendis.2014.06.001_bib41","first-page":"710","article-title":"Cationic liposome-mediated gene transfer","volume":"2","author":"Gao","year":"1995","journal-title":"Gene Ther"},{"issue":"4","key":"10.1016\/j.gendis.2014.06.001_bib42","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1021\/mp200121z","article-title":"Quantitative analysis of the leaky expression of adenovirus genes in cells transduced with a replication-incompetent adenovirus vector","volume":"8","author":"Shimizu","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.gendis.2014.06.001_bib43","series-title":"The Development of Human Gene Therapy","article-title":"Adenovirus vectors","author":"Wivel","year":"1999"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-0004.2000.580101.x","article-title":"Improvements in adenoviral vector technology: overcoming barriers for gene therapy","volume":"58","author":"Parks","year":"2000","journal-title":"Clin Genet"},{"issue":"5","key":"10.1016\/j.gendis.2014.06.001_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/156652307782151452","article-title":"Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects","volume":"7","author":"Seiler","year":"2007","journal-title":"Curr Gene Ther"},{"issue":"23","key":"10.1016\/j.gendis.2014.06.001_bib46","doi-asserted-by":"crossref","first-page":"13282","DOI":"10.1073\/pnas.241506298","article-title":"Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector","volume":"98","author":"Kim","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5 Pt 1","key":"10.1016\/j.gendis.2014.06.001_bib47","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1525-0016(03)00059-5","article-title":"Reduced inflammation and improved airway expression using helper-dependent adenoviral vectors with a K18 promoter","volume":"7","author":"Toietta","year":"2003","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"26","key":"10.1016\/j.gendis.2014.06.001_bib48","doi-asserted-by":"crossref","first-page":"15364","DOI":"10.1073\/pnas.2436478100","article-title":"Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia","volume":"100","author":"Koehler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.gendis.2014.06.001_bib49","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/jgm.797","article-title":"Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheter","volume":"7","author":"Koehler","year":"2005","journal-title":"J Gene Med"},{"key":"10.1016\/j.gendis.2014.06.001_bib50","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1038\/mtna.2013.55","article-title":"Efficient gene delivery to pig airway epithelia and submucosal glands using helper-dependent adenoviral vectors","volume":"2","author":"Cao","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"issue":"5","key":"10.1016\/j.gendis.2014.06.001_bib51","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1128\/JVI.70.5.3235-3241.1996","article-title":"In\u00a0vivo model of adeno-associated virus vector persistence and rescue","volume":"70","author":"Afione","year":"1996","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.gendis.2014.06.001_bib52","first-page":"658","article-title":"Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung","volume":"3","author":"Conrad","year":"1996","journal-title":"Gene Ther"},{"issue":"5","key":"10.1016\/j.gendis.2014.06.001_bib53","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1172\/JCI34316","article-title":"Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice","volume":"118","author":"Allocca","year":"2008","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/mt.2009.256","article-title":"Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2\u00a0kb","volume":"18","author":"Lai","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.gendis.2014.06.001_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc14d02s26","article-title":"Gene transfer in the lung using recombinant adeno-associated virus","author":"Gruntman","year":"2012","journal-title":"Curr Protoc Microbiol"},{"issue":"4","key":"10.1016\/j.gendis.2014.06.001_bib56","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/mthe.2001.0456","article-title":"Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison","volume":"4","author":"Duan","year":"2001","journal-title":"Mol Ther"},{"issue":"12","key":"10.1016\/j.gendis.2014.06.001_bib57","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1073\/pnas.97.12.6716","article-title":"Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy","volume":"97","author":"Yan","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.gendis.2014.06.001_bib58","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1089\/hum.2008.117","article-title":"Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells","volume":"19","author":"White","year":"2008","journal-title":"Hum Gene Ther"},{"issue":"12","key":"10.1016\/j.gendis.2014.06.001_bib59","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/mt.2009.155","article-title":"Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium","volume":"17","author":"Li","year":"2009","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.gendis.2014.06.001_bib60","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.bbamem.2013.11.014","article-title":"Mechanistic evaluation of the transfection barriers involved in lipid-mediated gene delivery: interplay between nanostructure and composition","volume":"1838","author":"Pozzi","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.gendis.2014.06.001_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.me.35.020184.000405","article-title":"The lung as an immunologic organ","volume":"35","author":"Bienenstock","year":"1984","journal-title":"Annu Rev Med"},{"issue":"5","key":"10.1016\/j.gendis.2014.06.001_bib62","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1073\/pnas.92.5.1401","article-title":"Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression","volume":"92","author":"Dai","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.gendis.2014.06.001_bib63","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1128\/JVI.69.4.2004-2015.1995","article-title":"Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses","volume":"69","author":"Yang","year":"1995","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ng1095-191","article-title":"Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration","volume":"11","author":"Kay","year":"1995","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.gendis.2014.06.001_bib65","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1073\/pnas.91.10.4407","article-title":"Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy","volume":"91","author":"Yang","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2014.06.001_bib66","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.imlet.2010.09.003","article-title":"Adenoviral vectors stimulate innate immune responses in macrophages through cross-talk with epithelial cells","volume":"134","author":"Lee","year":"2010","journal-title":"Immunol Lett"},{"issue":"9","key":"10.1016\/j.gendis.2014.06.001_bib68","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/gt.2009.87","article-title":"Progress and prospects: prospects of repeated pulmonary administration of viral vectors","volume":"16","author":"Sinn","year":"2009","journal-title":"Gene Ther"},{"issue":"20","key":"10.1016\/j.gendis.2014.06.001_bib69","doi-asserted-by":"crossref","first-page":"9655","DOI":"10.1128\/JVI.74.20.9655-9667.2000","article-title":"Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection","volume":"74","author":"Zsengeller","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.gendis.2014.06.001_bib70","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-kappa B and I kappa B proteins: new discoveries and insights","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib71","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.cr.7290275","article-title":"Down-regulation of IL-8 expression in human airway epithelial cells through helper-dependent adenoviral-mediated RNA interference","volume":"15","author":"Cao","year":"2005","journal-title":"Cell Res"},{"issue":"6","key":"10.1016\/j.gendis.2014.06.001_bib72","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1084\/jem.167.6.1883","article-title":"Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor","volume":"167","author":"Matsushima","year":"1988","journal-title":"J Exp Med"},{"issue":"6121","key":"10.1016\/j.gendis.2014.06.001_bib73","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I\u00a0interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/mt.2010.250","article-title":"The complex and evolving story of T cell activation to AAV vector-encoded transgene products","volume":"19","author":"Mays","year":"2011","journal-title":"Mol Ther"},{"issue":"5258","key":"10.1016\/j.gendis.2014.06.001_bib75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.272.5258.50","article-title":"The instructive role of innate immunity in the acquired immune response","volume":"272","author":"Fearon","year":"1996","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.gendis.2014.06.001_bib76","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/sj.gt.3300431","article-title":"Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway","volume":"4","author":"Scaria","year":"1997","journal-title":"Gene Ther"},{"issue":"9","key":"10.1016\/j.gendis.2014.06.001_bib77","doi-asserted-by":"crossref","first-page":"7542","DOI":"10.1128\/JVI.72.9.7542-7550.1998","article-title":"Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administration","volume":"72","author":"Wilson","year":"1998","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.gendis.2014.06.001_bib78","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/mthe.2002.0676","article-title":"Systemic delivery of a high-capacity adenoviral vector expressing mouse CTLA4Ig improves skeletal muscle gene therapy","volume":"6","author":"Jiang","year":"2002","journal-title":"Mol Ther"},{"issue":"7","key":"10.1016\/j.gendis.2014.06.001_bib79","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/01.TP.0000085651.20586.30","article-title":"Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies","volume":"76","author":"Yamashita","year":"2003","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/hum.1996.7.1-79","article-title":"\u201cSero-switch\u201d adenovirus-mediated in\u00a0vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype","volume":"7","author":"Mastrangeli","year":"1996","journal-title":"Hum Gene Ther"},{"issue":"22","key":"10.1016\/j.gendis.2014.06.001_bib81","doi-asserted-by":"crossref","first-page":"12360","DOI":"10.1128\/JVI.01010-07","article-title":"Lack of repeat transduction by recombinant adeno-associated virus type 5\/5 vectors in the mouse airway","volume":"81","author":"Sumner-Jones","year":"2007","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib82","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/hum.1997.8.1-99","article-title":"Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype","volume":"8","author":"Mack","year":"1997","journal-title":"Hum Gene Ther"},{"issue":"10","key":"10.1016\/j.gendis.2014.06.001_bib83","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1089\/hum.1998.9.10-1469","article-title":"Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential","volume":"9","author":"Kaplan","year":"1998","journal-title":"Hum Gene Ther"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib84","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/gt.2010.125","article-title":"Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression","volume":"18","author":"Cao","year":"2011","journal-title":"Gene Ther"},{"issue":"13","key":"10.1016\/j.gendis.2014.06.001_bib85","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1128\/JVI.74.13.6050-6057.2000","article-title":"Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer","volume":"74","author":"Pickles","year":"2000","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.gendis.2014.06.001_bib86","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1165\/ajrcmb.17.4.2714","article-title":"MUC1 and other sialoglycoconjugates inhibit adenovirus-mediated gene transfer to epithelial cells","volume":"17","author":"Arcasoy","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"7","key":"10.1016\/j.gendis.2014.06.001_bib87","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1128\/JVI.73.7.6085-6088.1999","article-title":"Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry","volume":"73","author":"Bals","year":"1999","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.gendis.2014.06.001_bib88","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1089\/hum.1997.8.14-1675","article-title":"Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract","volume":"8","author":"Worgall","year":"1997","journal-title":"Hum Gene Ther"},{"issue":"16","key":"10.1016\/j.gendis.2014.06.001_bib89","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/sj.gt.3302968","article-title":"Nacystelyn enhances adenoviral vector-mediated gene delivery to mouse airways","volume":"14","author":"Kushwah","year":"2007","journal-title":"Gene Ther"},{"issue":"3","key":"10.1016\/j.gendis.2014.06.001_bib90","first-page":"151","article-title":"Gadolinium chloride removes pulmonary intravascular macrophages and curtails the degree of ovine lentivirus-induced lymphoid interstitial pneumonia","volume":"79","author":"Singh","year":"1998","journal-title":"Int J Exp Pathol"},{"issue":"11","key":"10.1016\/j.gendis.2014.06.001_bib91","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/eji.1830211128","article-title":"Regulation of immune response to inhaled antigen by alveolar macrophages: differential effects of in\u00a0vivo alveolar macrophage elimination on the induction of tolerance vs. immunity","volume":"21","author":"Thepen","year":"1991","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/09629359791938","article-title":"Rooperol, an inhibitor of cytokine synthesis, decreases the respiratory burst in human and rat leukocytes and macrophages","volume":"6","author":"Guzdek","year":"1997","journal-title":"Mediators Inflamm"},{"issue":"2\u20133","key":"10.1016\/j.gendis.2014.06.001_bib93","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tox.2005.02.001","article-title":"Methyl palmitate: inhibitor of phagocytosis in primary rat Kupffer cells","volume":"210","author":"Cai","year":"2005","journal-title":"Toxicology"},{"issue":"6","key":"10.1016\/j.gendis.2014.06.001_bib94","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1567-5769(02)00018-8","article-title":"Modulation of rat macrophage function by the Mangifera indica L. extracts Vimang and mangiferin","volume":"2","author":"Garcia","year":"2002","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib95","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1183\/09031936.96.09020301","article-title":"Effect of in\u00a0vitro and in\u00a0vivo administration of dexamethasone on rat macrophage functions: comparison between alveolar and peritoneal macrophages","volume":"9","author":"Nakamura","year":"1996","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.gendis.2014.06.001_bib96","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/104303401300042348","article-title":"EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in\u00a0vivo","volume":"12","author":"Chu","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"16","key":"10.1016\/j.gendis.2014.06.001_bib97","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1089\/10430340260355365","article-title":"Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer","volume":"13","author":"Limberis","year":"2002","journal-title":"Hum Gene Ther"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib98","doi-asserted-by":"crossref","first-page":"L231","DOI":"10.1152\/ajplung.90209.2008","article-title":"Ciliated epithelial cell lifespan in the mouse trachea and lung","volume":"295","author":"Rawlins","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5644","key":"10.1016\/j.gendis.2014.06.001_bib99","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.gendis.2014.06.001_bib100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","article-title":"Efficacy of gene therapy for X-linked severe combined immunodeficiency","volume":"363","author":"Hacein-Bey-Abina","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gendis.2014.06.001_bib101","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1038\/mtna.2013.39","article-title":"Targeted myostatin gene editing in multiple mammalian species directed by a single pair of TALE nucleases","volume":"2","author":"Xu","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7355","key":"10.1016\/j.gendis.2014.06.001_bib102","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature10177","article-title":"In\u00a0vivo genome editing restores haemostasis in a mouse model of haemophilia","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib103","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3486","article-title":"TALENs: a widely applicable technology for targeted genome editing","volume":"14","author":"Joung","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"10.1016\/j.gendis.2014.06.001_bib104","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrg2842","article-title":"Genome editing with engineered zinc finger nucleases","volume":"11","author":"Urnov","year":"2010","journal-title":"Nat Rev Genet"},{"issue":"7042","key":"10.1016\/j.gendis.2014.06.001_bib105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/435577a","article-title":"Gene therapy: the moving finger","volume":"435","author":"High","year":"2005","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.gendis.2014.06.001_bib106","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1073\/pnas.0611478104","article-title":"Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases","volume":"104","author":"Moehle","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"10.1016\/j.gendis.2014.06.001_bib107","doi-asserted-by":"crossref","first-page":"9283","DOI":"10.1093\/nar\/gkr597","article-title":"A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity","volume":"39","author":"Mussolino","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"10.1016\/j.gendis.2014.06.001_bib108","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1093\/nar\/gkr188","article-title":"Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes","volume":"39","author":"Li","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.gendis.2014.06.001_bib109","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nbt.1927","article-title":"Genetic engineering of human pluripotent cells using TALE nucleases","volume":"29","author":"Hockemeyer","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"12","key":"10.1016\/j.gendis.2014.06.001_bib110","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1093\/nar\/gkr218","article-title":"Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting","volume":"39","author":"Cermak","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gendis.2014.06.001_bib111","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-genet-110410-132430","article-title":"CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation","volume":"45","author":"Bhaya","year":"2011","journal-title":"Annu Rev Genet"},{"issue":"3","key":"10.1016\/j.gendis.2014.06.001_bib112","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.mib.2011.03.005","article-title":"CRISPR-based adaptive immune systems","volume":"14","author":"Terns","year":"2011","journal-title":"Curr Opin Microbiol"},{"issue":"7385","key":"10.1016\/j.gendis.2014.06.001_bib113","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nature10886","article-title":"RNA-guided genetic silencing systems in bacteria and archaea","volume":"482","author":"Wiedenheft","year":"2012","journal-title":"Nature"},{"issue":"6096","key":"10.1016\/j.gendis.2014.06.001_bib114","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"7340","key":"10.1016\/j.gendis.2014.06.001_bib115","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature09886","article-title":"CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III","volume":"471","author":"Deltcheva","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2014.06.001_bib116","doi-asserted-by":"crossref","first-page":"e00471","DOI":"10.7554\/eLife.00471","article-title":"RNA-programmed genome editing in human cells","volume":"2","author":"Jinek","year":"2013","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.gendis.2014.06.001_bib117","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.cell.2013.08.022","article-title":"One-step generation of mice carrying reporter and conditional alleles by CRISPR\/Cas-mediated genome engineering","volume":"154","author":"Yang","year":"2013","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.gendis.2014.06.001_bib118","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1093\/nar\/gkt714","article-title":"CRISPR\/Cas9 systems targeting beta-globin and CCR5 genes have substantial off-target activity","volume":"41","author":"Cradick","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"10.1016\/j.gendis.2014.06.001_bib119","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/gt.2011.151","article-title":"Novel adeno-associated viral vectors for retinal gene therapy","volume":"19","author":"Vandenberghe","year":"2012","journal-title":"Gene Ther"},{"issue":"21","key":"10.1016\/j.gendis.2014.06.001_bib121","doi-asserted-by":"crossref","first-page":"15751","DOI":"10.1016\/S0021-9258(18)82319-5","article-title":"Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in\u00a0vitro","volume":"268","author":"Hamel","year":"1993","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib122","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1189\/jlb.1102574","article-title":"Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation","volume":"74","author":"Streilein","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.gendis.2014.06.001_bib123","first-page":"127","article-title":"Advances in gene therapy technologies to treat retinitis pigmentosa","volume":"8","author":"Petrs-Silva","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib124","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2045-3701-1-15","article-title":"Subretinal gene delivery using helper-dependent adenoviral vectors","volume":"1","author":"Wu","year":"2011","journal-title":"Cell Biosci"},{"issue":"11","key":"10.1016\/j.gendis.2014.06.001_bib125","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/gt.2008.66","article-title":"AAV-mediated gene therapy for retinal disorders: from mouse to man","volume":"15","author":"Buch","year":"2008","journal-title":"Gene Ther"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1165\/ajrcmb.24.2.3918","article-title":"New models of the tracheal airway define the glandular contribution to airway surface fluid and electrolyte composition","volume":"24","author":"Wang","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib127","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00234174","article-title":"The distribution and structure of cells in the tracheal epithelium of the mouse","volume":"208","author":"Pack","year":"1980","journal-title":"Cell Tissue Res"},{"issue":"2 Pt 2","key":"10.1016\/j.gendis.2014.06.001_bib128","first-page":"S4","article-title":"Structure as revealed by airway dissection. A comparison of mammalian lungs","volume":"128","author":"Plopper","year":"1983","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"10.1016\/j.gendis.2014.06.001_bib129","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1165\/ajrcmb.10.6.8003339","article-title":"Cell number and distribution in human and rat airways","volume":"10","author":"Mercer","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib130","doi-asserted-by":"crossref","first-page":"L240","DOI":"10.1152\/ajplung.90203.2008","article-title":"The porcine lung as a potential model for cystic fibrosis","volume":"295","author":"Rogers","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1016\/j.gendis.2014.06.001_bib131","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1172\/JCI34599","article-title":"Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets","volume":"118","author":"Sun","year":"2008","journal-title":"J Clin Invest"},{"issue":"5897","key":"10.1016\/j.gendis.2014.06.001_bib132","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.1163600","article-title":"Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs","volume":"321","author":"Rogers","year":"2008","journal-title":"Science"},{"issue":"8199","key":"10.1016\/j.gendis.2014.06.001_bib133","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(80)90189-0","article-title":"Interferon in human serum after injection of endotoxin","volume":"2","author":"Sauter","year":"1980","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.gendis.2014.06.001_bib134","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199305203282005","article-title":"Brief report: shock and multiple-organ dysfunction after self-administration of\u00a0Salmonella endotoxin","volume":"328","author":"Taveira da Silva","year":"1993","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.gendis.2014.06.001_bib135","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","article-title":"Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness","volume":"12","author":"Acland","year":"2005","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib136","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng0501-92","article-title":"Gene therapy restores vision in a canine model of childhood blindness","volume":"28","author":"Acland","year":"2001","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.gendis.2014.06.001_bib137","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ymthe.2006.03.005","article-title":"Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection","volume":"13","author":"Jacobson","year":"2006","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.gendis.2014.06.001_bib138","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1167\/iovs.02-0595","article-title":"Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog","volume":"44","author":"Narfstrom","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.gendis.2014.06.001_bib139","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jhered\/esg015","article-title":"In\u00a0vivo gene therapy in young and adult RPE65\u2212\/\u2212 dogs produces long-term visual improvement","volume":"94","author":"Narfstrom","year":"2003","journal-title":"J Hered"},{"issue":"2","key":"10.1016\/j.gendis.2014.06.001_bib140","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ymthe.2003.11.013","article-title":"In utero gene therapy rescues vision in a murine model of congenital blindness","volume":"9","author":"Dejneka","year":"2004","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.gendis.2014.06.001_bib141","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrmicro1615","article-title":"Virus trafficking \u2013 learning from single-virus tracking","volume":"5","author":"Brandenburg","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"5567","key":"10.1016\/j.gendis.2014.06.001_bib142","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.1069784","article-title":"Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae","volume":"296","author":"Pelkmans","year":"2002","journal-title":"Science"}],"container-title":["Genes &amp; Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304214000026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304214000026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:27:04Z","timestamp":1649723224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304214000026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":142,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S2352304214000026"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2014.06.001","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}